RxDoctor Payments Data

Ronak Desai, DO

Anesthesiology · Camden, NJNPI 1629181987

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Acacia Pharma Inc at 44.8% of the total. Reporting peaked in 2021 at $108,947 and has fallen 69.4% since, to $33,379 in 2025. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$342,960in general payments, 2019–2025

Across 431 payments — averaging $795.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acacia Pharma Inc$154K
  • Mallinckrodt Enterprises LLC$84K
  • Eagle Pharmaceuticals, Inc.$40K
  • Heron Therapeutics, Inc.$29K
  • Mallinckrodt Hospital Products Inc.$28K
  • Vertex$4K
  • plus $4K from 8 others
$40,635in research payments, 2019–2025

Across 1 payment — averaging $40,635 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$41K

What the payments were for

  • Consulting fees$95,19028%
  • Speaking & faculty fees$192,05056%
  • Travel & lodging$45,96213%
  • Food & beverage$9,7583%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$342,960 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$35,029
Medicare patients
130
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →